background soy isoflavones have antiestrogenic and anticancer properties but also possess estrogenlike properties which has raised concern about soy food consumption among breast cancer survivorsobjective we prospectively evaluated the association between postdiagnosis soy food consumption and breast cancer outcomes among us and chinese women by using data from the after breast cancer pooling projectdesign the analysis included 9514 breast cancer survivors with a diagnosis of invasive breast cancer between 1991 and 2006 from 2 us cohorts and 1 chinese cohortsoy isoflavone intake mgd was measured with validated foodfrequency questionnaireshrs and 95 cis were estimated by using delayedentry cox regression models adjusted for sociodemographic clinical and lifestyle factorsresults after a mean followup of 74 y we identified 1171 total deaths 881 from breast cancer and 1348 recurrencesdespite large differences in soy isoflavone intake by country isoflavone consumption was inversely associated with recurrence among both us and chinese women regardless of whether data were analyzed separately by country or combinedno heterogeneity was observedin the pooled analysis consumption of 10 mg isoflavonesd was associated with a nonsignificant reduced risk of allcause hr 087 95 ci 070 110 and breast cancerspecific hr 083 95 ci 064 107 mortality and a statistically significant reduced risk of recurrence hr 075 95 ci 061 092conclusion in this large study of combined data on us and chinese women postdiagnosis soy food consumption of 10 mg isoflavonesd was associated with a nonsignificant reduced risk of breast cancerspecific mortality and a statistically significant reduced risk of recurrenceone of the studies included in the after breast cancer pooling project the womens healthy eating  living study was registered at clinicaltrialsgov as nct00003787